Harnessing the power of foot-and-mouth-disease virus for targeting integrin alpha-v beta-6 for the therapy of cancer. (2021)
Attributed to:
Use of CRISPR/Cas9 Genome Library to dissect molecular control of endocytosis and trafficking in lung epithelia
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/17460441.2021.1878143
PubMed Identifier: 33533659
Publication URI: http://europepmc.org/abstract/MED/33533659
Type: Journal Article/Review
Volume: 16
Parent Publication: Expert opinion on drug discovery
Issue: 7
ISSN: 1746-0441